Candidemias e a resistência aos antifúngicos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Idioma: | por |
Título da fonte: | Repositório Institucional da UCB |
Texto Completo: | https://repositorio.ucb.br:9443/jspui/handle/10869/2757 |
Resumo: | Biomedicina |
id |
UCB-2_dd20f477015465854bcf03374517767d |
---|---|
oai_identifier_str |
oai:200.214.135.189:10869/2757 |
network_acronym_str |
UCB-2 |
network_name_str |
Repositório Institucional da UCB |
spelling |
Araújo, Flávia Caixêta2014-03-21T20:17:29Z2016-10-10T03:42:03Z2014-03-21T20:17:29Z2016-10-10T03:42:03Z2013-11-14ARAÚJO, Flávia Caixêta. Candidemias e a resistência aos antifúngicos. 2013. 26 f. Monografia (Graduação) - Universidade Católica de Brasília, Brasília, 2013.https://repositorio.ucb.br:9443/jspui/handle/10869/2757BiomedicinaAs infecções fúngicas invasivas causadas por Candida sp., também conhecidas como candidemias ou candidíases hematogênicas, aumentam a cada dia. Os grupos mais suscetíveis a essas infecções são os imunodeprimidos, neonatos de baixo peso e que estão sujeitos a condições hospitalares propícias, além dos idosos. Ainda são descritos como grupos de risco, pacientes em uso de antibióticos de largo espectro, uso de cateter venoso central e ventilação mecânica. A espécie mais comum causadora de candidemias é a Candida albicans, seguida por C. tropicalis, C. glabrata e C. parapsilosis. Mas sabe-se que várias espécies não patogênicas vêm emergindo como patógenos oportunistas, elevando a lista para 18 espécies descritas. A terapêutica se baseia no uso de antifúngicos, sendo 3 classes mais utilizadas, os azólicos (imidazólicos e triazólicos), antibióticos poliênicos e equinocandinas. Porém, muitas espécies apresentam resistência frente esses fármacos, o que dificulta o tratamento e eleva as chances de mortalidade dos pacientes. Devido a isso, a necessidade de metodologias para avaliação da resistência a antifúngicos vem surgindo, com o intuito de aplicar a terapêutica mais adequada a cada paciente.Invasive fungal infections caused by Candida sp., also known as candidemias or hematogenous candidiasis, are increasing every day. The groups more susceptible to these infections are immunosuppressed, newborns of low birth weight and that are subject to hospital conditions conducive, in addition to the elderly. Are still described as risk groups, patients using broad-spectrum antibiotics, use of central venous catheter and mechanical ventilation. The most common species causing candidemias is Candida albicans, followed by C. tropicalis, C. parapsilosis and C. glabrata. But it is known that several pathogenic species are emerging as opportunistic pathogens, bringing the list to 18 described species. The therapy is based on the use of antifungals, 3 more classes being used, the azole (imidazolyl and triazólicos), polienics antibiotics and equinocandinas. However, many species exhibit resistance these pharmaceuticals, which makes the treatment and raises the chances of the mortality of patients. Because of this, the need for methodologies for assessment of resistance to antifungals comes popping up, in order to apply the most appropriate therapy for each patient.Submitted by Juliana Pereira (juliana.pereira@ucb.br) on 2014-03-14T14:40:06Z No. of bitstreams: 2 license_rdf: 20168 bytes, checksum: 288037d582f66c131a3b54761360a7bc (MD5) TCC II - Flavia Caixeta Arapujo.pdf: 416330 bytes, checksum: 4dbff37a880f195584b521305f8ee283 (MD5)Approved for entry into archive by Kelson Anthony de Menezes(kelson@ucb.br) on 2014-03-21T20:17:29Z (GMT) No. of bitstreams: 2 license_rdf: 20168 bytes, checksum: 288037d582f66c131a3b54761360a7bc (MD5) TCC II - Flavia Caixeta Arapujo.pdf: 416330 bytes, checksum: 4dbff37a880f195584b521305f8ee283 (MD5)Made available in DSpace on 2014-03-21T20:17:29Z (GMT). No. of bitstreams: 2 license_rdf: 20168 bytes, checksum: 288037d582f66c131a3b54761360a7bc (MD5) TCC II - Flavia Caixeta Arapujo.pdf: 416330 bytes, checksum: 4dbff37a880f195584b521305f8ee283 (MD5) Previous issue date: 2013-11-14Made available in DSpace on 2016-10-10T03:42:03Z (GMT). No. of bitstreams: 5 Flavia Caixeta Arapujo: 416330 bytes, checksum: 4dbff37a880f195584b521305f8ee283 (MD5) license_url: 46 bytes, checksum: 0d2fb706760bf56ddf1358a832652ccf (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 20168 bytes, checksum: 288037d582f66c131a3b54761360a7bc (MD5) license.txt: 1877 bytes, checksum: 84662e9ff0de521fe5e714c111389722 (MD5) Previous issue date: 2013-11-14TextoCandidíase hematogênicaCandidemiaFungemiaBiomedicinaHematogenous candidiasisCandidemiaFungemiaCandidemias e a resistência aos antifúngicosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Católica de Brasília, Brasilinfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UCBinstname:Universidade Católica de Brasília (UCB)instacron:UCBORIGINALFlavia Caixeta ArapujoMonografiaapplication/octet-stream416330https://200.214.135.178:9443/jspui/bitstream/10869/2757/1/Flavia%20Caixeta%20Arapujo4dbff37a880f195584b521305f8ee283MD51CC-LICENSElicense_urlapplication/octet-stream46https://200.214.135.178:9443/jspui/bitstream/10869/2757/2/license_url0d2fb706760bf56ddf1358a832652ccfMD52license_textapplication/octet-stream0https://200.214.135.178:9443/jspui/bitstream/10869/2757/3/license_textd41d8cd98f00b204e9800998ecf8427eMD53license_rdfapplication/octet-stream20168https://200.214.135.178:9443/jspui/bitstream/10869/2757/4/license_rdf288037d582f66c131a3b54761360a7bcMD54LICENSElicense.txttext/plain1877https://200.214.135.178:9443/jspui/bitstream/10869/2757/5/license.txt84662e9ff0de521fe5e714c111389722MD5510869/27572016-10-10 00:42:03.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Repositório de Publicaçõeshttps://repositorio.ucb.br:9443/jspui/ |
dc.title.pt_BR.fl_str_mv |
Candidemias e a resistência aos antifúngicos |
title |
Candidemias e a resistência aos antifúngicos |
spellingShingle |
Candidemias e a resistência aos antifúngicos Araújo, Flávia Caixêta Candidíase hematogênica Candidemia Fungemia Biomedicina Hematogenous candidiasis Candidemia Fungemia |
title_short |
Candidemias e a resistência aos antifúngicos |
title_full |
Candidemias e a resistência aos antifúngicos |
title_fullStr |
Candidemias e a resistência aos antifúngicos |
title_full_unstemmed |
Candidemias e a resistência aos antifúngicos |
title_sort |
Candidemias e a resistência aos antifúngicos |
author |
Araújo, Flávia Caixêta |
author_facet |
Araújo, Flávia Caixêta |
author_role |
author |
dc.contributor.author.fl_str_mv |
Araújo, Flávia Caixêta |
dc.subject.por.fl_str_mv |
Candidíase hematogênica Candidemia Fungemia Biomedicina Hematogenous candidiasis Candidemia Fungemia |
topic |
Candidíase hematogênica Candidemia Fungemia Biomedicina Hematogenous candidiasis Candidemia Fungemia |
dc.description.pt_BR.fl_txt_mv |
Biomedicina |
dc.description.abstract.por.fl_txt_mv |
As infecções fúngicas invasivas causadas por Candida sp., também conhecidas como candidemias ou candidíases hematogênicas, aumentam a cada dia. Os grupos mais suscetíveis a essas infecções são os imunodeprimidos, neonatos de baixo peso e que estão sujeitos a condições hospitalares propícias, além dos idosos. Ainda são descritos como grupos de risco, pacientes em uso de antibióticos de largo espectro, uso de cateter venoso central e ventilação mecânica. A espécie mais comum causadora de candidemias é a Candida albicans, seguida por C. tropicalis, C. glabrata e C. parapsilosis. Mas sabe-se que várias espécies não patogênicas vêm emergindo como patógenos oportunistas, elevando a lista para 18 espécies descritas. A terapêutica se baseia no uso de antifúngicos, sendo 3 classes mais utilizadas, os azólicos (imidazólicos e triazólicos), antibióticos poliênicos e equinocandinas. Porém, muitas espécies apresentam resistência frente esses fármacos, o que dificulta o tratamento e eleva as chances de mortalidade dos pacientes. Devido a isso, a necessidade de metodologias para avaliação da resistência a antifúngicos vem surgindo, com o intuito de aplicar a terapêutica mais adequada a cada paciente. Invasive fungal infections caused by Candida sp., also known as candidemias or hematogenous candidiasis, are increasing every day. The groups more susceptible to these infections are immunosuppressed, newborns of low birth weight and that are subject to hospital conditions conducive, in addition to the elderly. Are still described as risk groups, patients using broad-spectrum antibiotics, use of central venous catheter and mechanical ventilation. The most common species causing candidemias is Candida albicans, followed by C. tropicalis, C. parapsilosis and C. glabrata. But it is known that several pathogenic species are emerging as opportunistic pathogens, bringing the list to 18 described species. The therapy is based on the use of antifungals, 3 more classes being used, the azole (imidazolyl and triazólicos), polienics antibiotics and equinocandinas. However, many species exhibit resistance these pharmaceuticals, which makes the treatment and raises the chances of the mortality of patients. Because of this, the need for methodologies for assessment of resistance to antifungals comes popping up, in order to apply the most appropriate therapy for each patient. |
description |
Biomedicina |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013-11-14 |
dc.date.accessioned.fl_str_mv |
2014-03-21T20:17:29Z 2016-10-10T03:42:03Z |
dc.date.available.fl_str_mv |
2014-03-21T20:17:29Z 2016-10-10T03:42:03Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ARAÚJO, Flávia Caixêta. Candidemias e a resistência aos antifúngicos. 2013. 26 f. Monografia (Graduação) - Universidade Católica de Brasília, Brasília, 2013. |
dc.identifier.uri.fl_str_mv |
https://repositorio.ucb.br:9443/jspui/handle/10869/2757 |
identifier_str_mv |
ARAÚJO, Flávia Caixêta. Candidemias e a resistência aos antifúngicos. 2013. 26 f. Monografia (Graduação) - Universidade Católica de Brasília, Brasília, 2013. |
url |
https://repositorio.ucb.br:9443/jspui/handle/10869/2757 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
Texto |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UCB instname:Universidade Católica de Brasília (UCB) instacron:UCB |
instname_str |
Universidade Católica de Brasília (UCB) |
instacron_str |
UCB |
institution |
UCB |
reponame_str |
Repositório Institucional da UCB |
collection |
Repositório Institucional da UCB |
bitstream.url.fl_str_mv |
https://200.214.135.178:9443/jspui/bitstream/10869/2757/1/Flavia%20Caixeta%20Arapujo https://200.214.135.178:9443/jspui/bitstream/10869/2757/2/license_url https://200.214.135.178:9443/jspui/bitstream/10869/2757/3/license_text https://200.214.135.178:9443/jspui/bitstream/10869/2757/4/license_rdf https://200.214.135.178:9443/jspui/bitstream/10869/2757/5/license.txt |
bitstream.checksum.fl_str_mv |
4dbff37a880f195584b521305f8ee283 0d2fb706760bf56ddf1358a832652ccf d41d8cd98f00b204e9800998ecf8427e 288037d582f66c131a3b54761360a7bc 84662e9ff0de521fe5e714c111389722 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1724829814222749696 |